The elastography imaging market size has grown rapidly in recent years. It will grow from $3.87 billion in 2025 to $4.27 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of liver and musculoskeletal disorders, expansion of diagnostic imaging services, rising adoption of ultrasound-based diagnostics, growing clinical awareness of tissue stiffness assessment, availability of advanced imaging modalities.
The elastography imaging market size is expected to see rapid growth in the next few years. It will grow to $6.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted imaging analysis, rising demand for early-stage disease diagnosis, expansion of elastography use in oncology and cardiology, growing investments in advanced imaging infrastructure, increasing preference for non-invasive diagnostic techniques. Major trends in the forecast period include increasing adoption of shear wave elastography, rising use of non-invasive diagnostic imaging, growing integration of elastography with ultrasound systems, expansion of multi-organ diagnostic applications, enhanced focus on early disease detection.
The anticipated increase in the elastography imaging market is expected to be driven by the growing incidence of chronic liver and breast cancer. Chronic liver and breast cancer involve the uncontrolled growth and multiplication of liver cells, leading to life-threatening conditions. Elastography, a technique based on ultrasound (US), is commonly utilized in hepatology to assess liver stiffness in individuals with chronic liver disease. Consequently, the rising prevalence of chronic liver and breast cancer is poised to fuel the growth of the elastography imaging market. For example, data from the 'Cancer Facts And Figures 2023' report by the American Cancer Society, a nationwide voluntary health organization in the United States, revealed an increase in new cases of liver and intrahepatic bile duct cancer in females, rising from 12,640 in 2020 to 13,230 in 2023.
Major companies in the elastography imaging devices market are increasingly focusing on developing advanced solutions, such as premium ultrasound systems, to improve tissue stiffness assessment, enhance diagnostic accuracy, and streamline clinical workflows. Premium ultrasound systems are sophisticated imaging devices offering high-resolution imaging, faster processing, and specialized features like elastography, 3D/4D imaging, and AI-assisted diagnostics to support clinical precision. For example, in November 2024, Shenzhen Mindray Bio-medical Electronics Co., Ltd., a China-based manufacturer, launched the Resona A20, a premium ultrasound system designed to provide advanced imaging and AI-powered clinical tools for radiology and multi-specialty applications. The system integrates Acoustic Intelligence Technology (AIT) and next-generation AFM transducers to deliver exceptional image quality across diverse clinical scenarios. It features AI-driven tools such as Smart Breast, Smart Thyroid, and Automated Liver STE to optimize workflow and diagnostic accuracy. Key innovations include super-resolution contrast-enhanced ultrasound for microcirculation imaging, multi-parametric liver and breast tools including visco-elastography for tissue stiffness evaluation, and ultra-micro angiography with high-frame-rate imaging for detailed visualization of blood flow and anatomical structures.
In January 2024, Mindray North America Inc., a medical device company based in the United States, joined forces with Aegle Medical Solutions Inc. to incorporate advanced medical imaging solutions aimed at improving patient monitoring. Through this collaboration, Mindray and Aegle Medical Solutions intend to advance the development and integration of elastography imaging technologies, ultimately enhancing patient diagnosis and monitoring in healthcare environments. Aegle Medical Solutions Inc. is also a medical technology company located in the United States.
Major companies operating in the elastography imaging market are Canon Medical Systems Corporation, Esaote S.p.A., GE Healthcare Technologies Inc., Koninklijke Philips N.V., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Siemens Healthineers AG, Toshiba America Medical Systems Inc., SuperSonic Imagine, Resoundant Inc., Shimadzu Corporation, BK Medical Holding Company Inc., SonoScape Medical Corp., Hitachi Medical Systems, Fujifilm Holdings Corporation, Exact Imaging Inc., Echosens, Konica Minolta Healthcare Americas Inc., QT Ultrasound LLC, Healcerion Co. Ltd., EDAP TMS Inc.
Asia-pacific was the largest region in the elastography imaging market in 2025. The regions covered in the elastography imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the elastography imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the elastography imaging market by increasing costs of imported imaging transducers, sensors, electronic components, and advanced software modules. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported imaging systems, while Asia-Pacific faces higher equipment procurement costs. These tariffs are raising capital expenditure requirements for healthcare providers. However, they are also encouraging regional manufacturing, localized system integration, and increased development of cost-effective elastography imaging solutions.
The elastography imaging market research report is one of a series of new reports that provides elastography imaging market statistics, including elastography imaging industry global market size, regional shares, competitors with a elastography imaging market share, detailed elastography imaging market segments, market trends and opportunities, and any further data you may need to thrive in the elastography imaging industry. This elastography imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Elastography imaging is a non-invasive diagnostic technology designed to assess the rigidity of organs and various body components. This method involves utilizing painless, low-frequency vibrations to determine the stiffness of tissues and organs, aiding in the diagnosis of related disorders.
Two primary modes of elastography imaging are ultrasound and magnetic resonance. Ultrasound, also known as sonography, is an imaging technique that employs high-frequency sound waves to visualize the interior organs and connective tissues such as muscles. This method is valuable for identifying the root causes of discomfort, edema, and diseases affecting the body's internal organs. Elastography imaging finds applications in various medical fields, including radiology, cardiology, obstetrics, urology, vascular, orthopedic, musculoskeletal, and others. These applications are utilized by hospitals, ambulatory surgery centers, and other healthcare facilities.
The elastography imaging market consists of sales of one-dimensional transient elastography, point shear wave elastography, and two-dimensional shear wave elastography. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The elastography imaging market size is expected to see rapid growth in the next few years. It will grow to $6.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted imaging analysis, rising demand for early-stage disease diagnosis, expansion of elastography use in oncology and cardiology, growing investments in advanced imaging infrastructure, increasing preference for non-invasive diagnostic techniques. Major trends in the forecast period include increasing adoption of shear wave elastography, rising use of non-invasive diagnostic imaging, growing integration of elastography with ultrasound systems, expansion of multi-organ diagnostic applications, enhanced focus on early disease detection.
The anticipated increase in the elastography imaging market is expected to be driven by the growing incidence of chronic liver and breast cancer. Chronic liver and breast cancer involve the uncontrolled growth and multiplication of liver cells, leading to life-threatening conditions. Elastography, a technique based on ultrasound (US), is commonly utilized in hepatology to assess liver stiffness in individuals with chronic liver disease. Consequently, the rising prevalence of chronic liver and breast cancer is poised to fuel the growth of the elastography imaging market. For example, data from the 'Cancer Facts And Figures 2023' report by the American Cancer Society, a nationwide voluntary health organization in the United States, revealed an increase in new cases of liver and intrahepatic bile duct cancer in females, rising from 12,640 in 2020 to 13,230 in 2023.
Major companies in the elastography imaging devices market are increasingly focusing on developing advanced solutions, such as premium ultrasound systems, to improve tissue stiffness assessment, enhance diagnostic accuracy, and streamline clinical workflows. Premium ultrasound systems are sophisticated imaging devices offering high-resolution imaging, faster processing, and specialized features like elastography, 3D/4D imaging, and AI-assisted diagnostics to support clinical precision. For example, in November 2024, Shenzhen Mindray Bio-medical Electronics Co., Ltd., a China-based manufacturer, launched the Resona A20, a premium ultrasound system designed to provide advanced imaging and AI-powered clinical tools for radiology and multi-specialty applications. The system integrates Acoustic Intelligence Technology (AIT) and next-generation AFM transducers to deliver exceptional image quality across diverse clinical scenarios. It features AI-driven tools such as Smart Breast, Smart Thyroid, and Automated Liver STE to optimize workflow and diagnostic accuracy. Key innovations include super-resolution contrast-enhanced ultrasound for microcirculation imaging, multi-parametric liver and breast tools including visco-elastography for tissue stiffness evaluation, and ultra-micro angiography with high-frame-rate imaging for detailed visualization of blood flow and anatomical structures.
In January 2024, Mindray North America Inc., a medical device company based in the United States, joined forces with Aegle Medical Solutions Inc. to incorporate advanced medical imaging solutions aimed at improving patient monitoring. Through this collaboration, Mindray and Aegle Medical Solutions intend to advance the development and integration of elastography imaging technologies, ultimately enhancing patient diagnosis and monitoring in healthcare environments. Aegle Medical Solutions Inc. is also a medical technology company located in the United States.
Major companies operating in the elastography imaging market are Canon Medical Systems Corporation, Esaote S.p.A., GE Healthcare Technologies Inc., Koninklijke Philips N.V., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Siemens Healthineers AG, Toshiba America Medical Systems Inc., SuperSonic Imagine, Resoundant Inc., Shimadzu Corporation, BK Medical Holding Company Inc., SonoScape Medical Corp., Hitachi Medical Systems, Fujifilm Holdings Corporation, Exact Imaging Inc., Echosens, Konica Minolta Healthcare Americas Inc., QT Ultrasound LLC, Healcerion Co. Ltd., EDAP TMS Inc.
Asia-pacific was the largest region in the elastography imaging market in 2025. The regions covered in the elastography imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the elastography imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the elastography imaging market by increasing costs of imported imaging transducers, sensors, electronic components, and advanced software modules. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported imaging systems, while Asia-Pacific faces higher equipment procurement costs. These tariffs are raising capital expenditure requirements for healthcare providers. However, they are also encouraging regional manufacturing, localized system integration, and increased development of cost-effective elastography imaging solutions.
The elastography imaging market research report is one of a series of new reports that provides elastography imaging market statistics, including elastography imaging industry global market size, regional shares, competitors with a elastography imaging market share, detailed elastography imaging market segments, market trends and opportunities, and any further data you may need to thrive in the elastography imaging industry. This elastography imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Elastography imaging is a non-invasive diagnostic technology designed to assess the rigidity of organs and various body components. This method involves utilizing painless, low-frequency vibrations to determine the stiffness of tissues and organs, aiding in the diagnosis of related disorders.
Two primary modes of elastography imaging are ultrasound and magnetic resonance. Ultrasound, also known as sonography, is an imaging technique that employs high-frequency sound waves to visualize the interior organs and connective tissues such as muscles. This method is valuable for identifying the root causes of discomfort, edema, and diseases affecting the body's internal organs. Elastography imaging finds applications in various medical fields, including radiology, cardiology, obstetrics, urology, vascular, orthopedic, musculoskeletal, and others. These applications are utilized by hospitals, ambulatory surgery centers, and other healthcare facilities.
The elastography imaging market consists of sales of one-dimensional transient elastography, point shear wave elastography, and two-dimensional shear wave elastography. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Elastography Imaging Market Characteristics
3. Elastography Imaging Market Supply Chain Analysis
4. Global Elastography Imaging Market Trends and Strategies
5. Elastography Imaging Market Analysis of End Use Industries
7. Global Elastography Imaging Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Elastography Imaging Total Addressable Market (TAM) Analysis for the Market
9. Elastography Imaging Market Segmentation
10. Elastography Imaging Market Regional and Country Analysis
11. Asia-Pacific Elastography Imaging Market
12. China Elastography Imaging Market
13. India Elastography Imaging Market
14. Japan Elastography Imaging Market
15. Australia Elastography Imaging Market
16. Indonesia Elastography Imaging Market
17. South Korea Elastography Imaging Market
18. Taiwan Elastography Imaging Market
19. South East Asia Elastography Imaging Market
20. Western Europe Elastography Imaging Market
21. UK Elastography Imaging Market
22. Germany Elastography Imaging Market
23. France Elastography Imaging Market
24. Italy Elastography Imaging Market
25. Spain Elastography Imaging Market
26. Eastern Europe Elastography Imaging Market
27. Russia Elastography Imaging Market
28. North America Elastography Imaging Market
29. USA Elastography Imaging Market
30. Canada Elastography Imaging Market
31. South America Elastography Imaging Market
32. Brazil Elastography Imaging Market
33. Middle East Elastography Imaging Market
34. Africa Elastography Imaging Market
36. Elastography Imaging Market Competitive Landscape and Company Profiles
37. Elastography Imaging Market Other Major and Innovative Companies
40. Elastography Imaging Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Elastography Imaging Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses elastography imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for elastography imaging? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The elastography imaging market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Modality: Ultrasound; Magnetic Resonance2) By Application: Radiology; Cardiology; Obstetrics; Urology; Vascular; Orthopedic and Musculoskeletal; Other Applications
3) By End Use: Hospitals; Ambulatory Surgery Centers; Other End Uses
Subsegments:
1) By Ultrasound: Shear Wave Elastography (SWE); Strain Elastography; Acoustic Radiation Force Impulse (ARFI) Imaging2) By Magnetic Resonance: Magnetic Resonance Elastography (MRE); Diffusion-Weighted Imaging (DWI) With Elastography
Companies Mentioned: Canon Medical Systems Corporation; Esaote S.p.A.; GE Healthcare Technologies Inc.; Koninklijke Philips N.V.; Mindray Bio-Medical Electronics Co. Ltd.; Samsung Medison Co. Ltd.; Siemens Healthineers AG; Toshiba America Medical Systems Inc.; SuperSonic Imagine; Resoundant Inc.; Shimadzu Corporation; BK Medical Holding Company Inc.; SonoScape Medical Corp.; Hitachi Medical Systems; Fujifilm Holdings Corporation; Exact Imaging Inc.; Echosens; Konica Minolta Healthcare Americas Inc.; QT Ultrasound LLC; Healcerion Co. Ltd.; EDAP TMS Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Elastography Imaging market report include:- Canon Medical Systems Corporation
- Esaote S.p.A.
- GE Healthcare Technologies Inc.
- Koninklijke Philips N.V.
- Mindray Bio-Medical Electronics Co. Ltd.
- Samsung Medison Co. Ltd.
- Siemens Healthineers AG
- Toshiba America Medical Systems Inc.
- SuperSonic Imagine
- Resoundant Inc.
- Shimadzu Corporation
- BK Medical Holding Company Inc.
- SonoScape Medical Corp.
- Hitachi Medical Systems
- Fujifilm Holdings Corporation
- Exact Imaging Inc.
- Echosens
- Konica Minolta Healthcare Americas Inc.
- QT Ultrasound LLC
- Healcerion Co. Ltd.
- EDAP TMS Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.27 Billion |
| Forecasted Market Value ( USD | $ 6.41 Billion |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
